Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 6/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.48 |
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | NPC1 | O15118 | 3/20 | 0.45 |
| ▸ | RAB9A | P51151 | 3/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | PTPRC | P08575 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14867769 | 1.00 | PDK2 (0.58) | PDK2SMN1; SMN2LMNAMEN1KMT2A | |
| SCHEMBL29438557 | 1.00 | PDK2 (0.58) | PDK2SMN1; SMN2LMNAMEN1KMT2A | |
| SCHEMBL29362446 | 0.90 | PDK2 (0.54) | PDK2SMN1; SMN2LMNAMEN1KMT2A | |
| SCHEMBL344471 | 0.90 | PDK2 (0.54) | PDK2SMN1; SMN2LMNAMEN1KMT2A | |
| SCHEMBL29361678 | 0.90 | PDK2 (0.54) | PDK2SMN1; SMN2LMNAMEN1KMT2A | |
| SCHEMBL17528668 | 0.89 | PDK2 (0.42) | PDK2SMN1; SMN2LMNAMEN1KMT2A | |
| SCHEMBL13907822 | 0.88 | PDK2 (0.53) | PDK2SMN1; SMN2LMNAMEN1KMT2A | |
| SCHEMBL10043608 | 0.88 | PDK2 (0.53) | PDK2SMN1; SMN2LMNAMEN1KMT2A | |
| SCHEMBL23546585 | 0.85 | PDK2 (0.42) | PDK2SMN1; SMN2LMNAMEN1KMT2A | |
| SCHEMBL16585540 | 0.85 | PDK2 (0.53) | PDK2SMN1; SMN2LMNAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4263544-B1 | INDOLO[3.2.1-JK]CARBAZOLE-6-CARBONITRILE DERIVATIVES AS BLUE EMITTERS IN OLEDS | UDC IRELAND LTD (IE) | 2026-05-13 | — | — | EP | disclosed |
| EP-4676208-A2 | NITROGEN-CONTAINING HETERO-AROMATICS FOR ORGANIC ELECTROLUMINESCENT DEVICES | Merck Patent GmbH (DE) | 2026-01-07 | — | — | EP | disclosed |
| EP-4263746-B1 | NITROGENOUS HETEROAROMATIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2025-10-01 | — | — | EP | disclosed |
| CN-118026858-B | Luminescent auxiliary material and preparation method and application thereof | 吉林奥来德光电材料股份有限公司 | 2024-08-02 | — | — | CN | disclosed |
| CN-118026858-A | Luminescent auxiliary material and preparation method and application thereof | 吉林奥来德光电材料股份有限公司 | 2024-05-14 | — | — | CN | disclosed |
| US-20240101560-A1 | NITROGENOUS HETEROAROMATIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES | UDC IRELAND LIMITED (IE) | 2024-03-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240101560-A1 | NITROGENOUS HETEROAROMATIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES | NES, NCL, NPM1 | PDK2 2084/4885SMN1; SMN2 3971/4885LMNA 3730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.